431 related articles for article (PubMed ID: 26188135)
1. A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2015 Update.
Martin P; Lau DT; Nguyen MH; Janssen HL; Dieterich DT; Peters MG; Jacobson IM
Clin Gastroenterol Hepatol; 2015 Nov; 13(12):2071-87.e16. PubMed ID: 26188135
[TBL] [Abstract][Full Text] [Related]
2. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update.
Keeffe EB; Dieterich DT; Han SH; Jacobson IM; Martin P; Schiff ER; Tobias H; Wright TL
Clin Gastroenterol Hepatol; 2006 Aug; 4(8):936-62. PubMed ID: 16844425
[TBL] [Abstract][Full Text] [Related]
3. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update.
Keeffe EB; Dieterich DT; Han SH; Jacobson IM; Martin P; Schiff ER; Tobias H
Clin Gastroenterol Hepatol; 2008 Dec; 6(12):1315-41; quiz 1286. PubMed ID: 18845489
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and treatment of chronic hepatitis B: 2009 update.
Morgan M; Keeffe EB
Minerva Gastroenterol Dietol; 2009 Mar; 55(1):5-22. PubMed ID: 19212304
[TBL] [Abstract][Full Text] [Related]
5. Treatment of chronic hepatitis B: Evolution over two decades.
Yuen MF; Lai CL
J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():138-43. PubMed ID: 21199525
[TBL] [Abstract][Full Text] [Related]
6. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States.
Keeffe EB; Dieterich DT; Han SH; Jacobson IM; Martin P; Schiff ER; Tobias H; Wright TL
Clin Gastroenterol Hepatol; 2004 Feb; 2(2):87-106. PubMed ID: 15017613
[TBL] [Abstract][Full Text] [Related]
7. Treatment of chronic hepatitis B virus infection - Dutch national guidelines.
Buster EH; van Erpecum KJ; Schalm SW; Zaaijer HL; Brouwer JT; Gelderblom HC; de Knegt RJ; Minke Bakker C; Reesink HW; Janssen HL;
Neth J Med; 2008; 66(7):292-306. PubMed ID: 18663260
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus DNA and hepatitis B surface antigen levels in chronic hepatitis B.
Fung J; Lai CL; Yuen MF
Expert Rev Anti Infect Ther; 2010 Jun; 8(6):717-26. PubMed ID: 20521898
[TBL] [Abstract][Full Text] [Related]
9. Management of chronic hepatitis B virus infection: a new era of disease control.
Farrell GC; Teoh NC
Intern Med J; 2006 Feb; 36(2):100-13. PubMed ID: 16472264
[TBL] [Abstract][Full Text] [Related]
10. Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B.
Marcellin P; Heathcote EJ; Buti M; Gane E; de Man RA; Krastev Z; Germanidis G; Lee SS; Flisiak R; Kaita K; Manns M; Kotzev I; Tchernev K; Buggisch P; Weilert F; Kurdas OO; Shiffman ML; Trinh H; Washington MK; Sorbel J; Anderson J; Snow-Lampart A; Mondou E; Quinn J; Rousseau F
N Engl J Med; 2008 Dec; 359(23):2442-55. PubMed ID: 19052126
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and treatment of chronic hepatitis B: an update.
Morgan M; Park W; Keeffe EB
Minerva Gastroenterol Dietol; 2007 Mar; 53(1):25-41. PubMed ID: 17415343
[TBL] [Abstract][Full Text] [Related]
12. Long-term entecavir or tenofovir disoproxil fumarate therapy in treatment-naïve chronic hepatitis B patients in the real-world setting.
Idilman R; Gunsar F; Koruk M; Keskin O; Meral CE; Gulsen M; Elhan AH; Akarca US; Yurdaydin C
J Viral Hepat; 2015 May; 22(5):504-10. PubMed ID: 25431108
[TBL] [Abstract][Full Text] [Related]
13. Management of Chronic Hepatitis B: An Overview of Practice Guidelines for Primary Care Providers.
Han SH; Tran TT
J Am Board Fam Med; 2015; 28(6):822-37. PubMed ID: 26546661
[TBL] [Abstract][Full Text] [Related]
14. Chronic hepatitis B: preventing, detecting, and managing viral resistance.
Keeffe EB; Dieterich DT; Pawlotsky JM; Benhamou Y
Clin Gastroenterol Hepatol; 2008 Mar; 6(3):268-74. PubMed ID: 18328434
[TBL] [Abstract][Full Text] [Related]
15. A comparison of telbivudine and entecavir for chronic hepatitis B in real-world clinical practice.
Tsai MC; Lee CM; Chiu KW; Hung CH; Tung WC; Chen CH; Tseng PL; Chang KC; Wang JH; Lu SN; Yen YH; Hu TH
J Antimicrob Chemother; 2012 Mar; 67(3):696-9. PubMed ID: 22174039
[TBL] [Abstract][Full Text] [Related]
16. Early hepatitis B virus DNA reduction in hepatitis B e antigen-positive patients with chronic hepatitis B: A randomized international study of entecavir versus adefovir.
Leung N; Peng CY; Hann HW; Sollano J; Lao-Tan J; Hsu CW; Lesmana L; Yuen MF; Jeffers L; Sherman M; Min A; Mencarini K; Diva U; Cross A; Wilber R; Lopez-Talavera J
Hepatology; 2009 Jan; 49(1):72-9. PubMed ID: 19065670
[TBL] [Abstract][Full Text] [Related]
17. A 24-week, parallel-group, open-label, randomized clinical trial comparing the early antiviral efficacy of telbivudine and entecavir in the treatment of hepatitis B e antigen-positive chronic hepatitis B virus infection in adult Chinese patients.
Zheng MH; Shi KQ; Dai ZJ; Ye C; Chen YP
Clin Ther; 2010 Apr; 32(4):649-58. PubMed ID: 20435234
[TBL] [Abstract][Full Text] [Related]
18. Three years of continuous entecavir therapy in treatment-naïve chronic hepatitis B patients: VIRAL suppression, viral resistance, and clinical safety.
Yuen MF; Seto WK; Fung J; Wong DK; Yuen JC; Lai CL
Am J Gastroenterol; 2011 Jul; 106(7):1264-71. PubMed ID: 21364549
[TBL] [Abstract][Full Text] [Related]
19. Comparison of lamivudine plus adefovir therapy versus entecavir with or without adefovir therapy for adefovir-resistant chronic hepatitis B.
Kang SH; Yim HJ; Kim HR; Kang K; Suh SJ; Lee HJ; Yoon EL; Kim JH; Seo YS; Yeon JE; Byun KS
J Clin Gastroenterol; 2014; 48(10):889-95. PubMed ID: 24440937
[TBL] [Abstract][Full Text] [Related]
20. Therapy of chronic hepatitis B: trends and developments.
Delaney WE; Borroto-Esoda K
Curr Opin Pharmacol; 2008 Oct; 8(5):532-40. PubMed ID: 18835366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
